Senesco Technologies, Inc. (SNTI)…, a clinical-stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today a corporate rebranding under which the Company will change its name to Sevion Therapeutics, Inc. The Company will continue to trade as SNTI until a new ticker symbol is obtained.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”